|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The PIK3CAgene as a mutated target for cancer therapy显示文摘 | Gustin JP Cosgrove DP Park BH | 2008 | Curr Cancer Drug Targets2008，8，8： | 1 |
| 2 | Hilar cholangiocareino- ma: diagnosis, treatment options, and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepato- biliary Surg Nutr2014，3，1： | 1 |
| 3 | Hilar cholangiocarcinoma:diagnosis,treatment options,and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobiliary Surg Nutr2014，3，1： | 1 |
| 4 | Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary 显示文摘 | Liu C Bayer A Cosgrove SE Daum RS Fridkin SK Gorwitz RJ Kaplan SL Karchmer A W Levine DP Murray BE J Rybak M Talan DA Chambers HF | 2011 | Clin Infect Dis2011，52，3： | 1 |
| 5 | Hilar cholangiocar- cinom//i diagnosis, treatment options, and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobiliary Surg Nutr2014，3，1： | 1 |
| 6 | Trametinib dimethyl sulfoxide map kinase 1 and 2 (MEK 1/2) inhibitor oncolytic显示文摘 | Cosgrove DP | | 0，，12： | 1 |
| 7 | Hilar cholangiocarcinoma: diagnosis, treatment options, and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobiliary Surg Nutr2014，3，1： | 1 |
| 8 | Hilar cholangiocarcinoma:diagnosis,treatment options,and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobiliary Surg Nutr2014，3，1： | 1 |
| 9 | Hilar cholangiocarcino- ma: diagnosis, treatment options, and management 显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobi- liary Surg Nutr2014，3，1： | 1 |
| 10 | Hilar cholangio- carcinoma: diagnosis, treatment options, and management显示文摘 | Soares KC Kamel I Cosgrove DP | 2014 | Hepatobiliary Surg Nutr2014，3，： | 1 |
| 11 | Nuclcotide supplementation and the growth of term small for gestational age infants显示文摘 | Cosgrove M Davies DP Jenkins HR | 1996 | Arch Dis Child Fetal Neonatal Ed1996，74，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员